{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:19:32Z","timestamp":1774628372153,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Longfonds BREATH Consortia","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"MRC UKRMP2 Consortia","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Garfield Weston Trust","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"University College London Hospitals Charitable Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","award":["SU2C-AACR-DT23-17"],"award-info":[{"award-number":["SU2C-AACR-DT23-17"]}],"id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ruth Strauss Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT23-17"],"award-info":[{"award-number":["SU2C-AACR-DT23-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDCPGM\\100002"],"award-info":[{"award-number":["EDDCPGM\\100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020252","name":"CRUK Lung Cancer Centre of Excellence","doi-asserted-by":"publisher","award":["C11496\/ A30025"],"award-info":[{"award-number":["C11496\/ A30025"]}],"id":[{"id":"10.13039\/501100020252","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRUK City of London Centre","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCL\/UCLH NIHR Biomedical Research Centre","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T02481X\/1"],"award-info":[{"award-number":["MR\/T02481X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W025051\/1"],"award-info":[{"award-number":["MR\/W025051\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,3,7]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Next-Generation Sequencing (NGS) allows the use of more efficacious targeted treatments for lung cancer; however, sample inadequacy can cause delays in patient pathways. Here, we compare various methods of tissue acquisition used in clinical practice and identify factors associated with inadequate sampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Specimens submitted for NGS from a large single-centre UK academic institution following confirmation of lung cancer were reviewed. The primary objectives were to assess the proportion in which such analysis was successfully completed and identify factors, including the method of tissue acquisition, associated with sample inadequacy for, or failure of, the analysis. Secondary analyses included an assessment of genomic alterations identified by NGS-based analysis and specimen processing times.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DNA-based NGS analysis was successfully completed in 87.1% (n=511\/587) of all specimens, with known oncogenic driver variants being identified in 60.6% (n=310\/511). Success rates for specific specimen acquisition techniques included 90.0% (n=126\/140) for endobronchial ultrasound-guided transbronchial needle aspiration, 79.3% (n=88\/111) for percutaneous image-guided lung biopsies, 66.7% (n=14\/21) for pleural fluid cell blocks and 60% (n=9\/15) for percutaneous image-guided pleural biopsies.<\/jats:p>\n                    <jats:p>Sequential RNA-based NGS analysis was successfully completed in 81.4% (n=92\/113) cases, yielding a further 20 fusion gene events. Overall, actionable genomic alterations were identified in a total of 28.0% (n=143\/511) of specimens across DNA-based and RNA-based analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pleural fluid cell blocks and percutaneous image-guided pleural biopsies were least likely to be associated with successful NGS-based processing. Where possible, other sites for tissue acquisition should be considered in individuals with pleural disease to prevent delays in their pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003793","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:45:15Z","timestamp":1774626315000},"page":"e003793","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of tissue acquisition techniques for Next-Generation Sequencing of non-small cell lung cancer (NSCLC)"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8575-6119","authenticated-orcid":false,"given":"Amyn","family":"Bhamani","sequence":"first","affiliation":[{"name":"Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-6545","authenticated-orcid":false,"given":"Sindhu Bhaarrati","family":"Naidu","sequence":"additional","affiliation":[{"name":"Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naimish","family":"Adroja","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Rogers","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Anandan","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Bennett","sequence":"additional","affiliation":[{"name":"Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Ahmad","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D","family":"Forster","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asia","family":"Ahmed","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricky","family":"Thakrar","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam M","family":"Janes","sequence":"additional","affiliation":[{"name":"Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK"},{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Moore","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Navani","sequence":"additional","affiliation":[{"name":"Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK"},{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2026032708450718000_13.1.e003793.1","unstructured":"Cancer Research UK . Lung cancer statistics. 2022. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/lung-cancer"},{"key":"2026032708450718000_13.1.e003793.2","unstructured":"National lung cancer audit: NLCA state of the nation report. 2024. Available: https:\/\/www.lungcanceraudit.org.uk\/wp-content\/uploads\/2024\/04\/NLCA-State-of-the-Nation-Report-2024.pdf"},{"key":"2026032708450718000_13.1.e003793.3","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304340"},{"key":"2026032708450718000_13.1.e003793.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.014"},{"key":"2026032708450718000_13.1.e003793.5","doi-asserted-by":"crossref","unstructured":"Chin ELH , da Silva C , Hegde M . Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet 2013;14. doi:10.1186\/1471-2156-14-6","DOI":"10.1186\/1471-2156-14-6"},{"key":"2026032708450718000_13.1.e003793.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.10.007"},{"key":"2026032708450718000_13.1.e003793.7","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205319"},{"key":"2026032708450718000_13.1.e003793.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2683"},{"key":"2026032708450718000_13.1.e003793.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00356","article-title":"Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic Model","volume":"3","author":"Pennell","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"2026032708450718000_13.1.e003793.10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/13696998.2022.2053403","article-title":"Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer","volume":"25","author":"Vanderpoel","year":"2022","journal-title":"J Med Econ"},{"key":"2026032708450718000_13.1.e003793.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040938"},{"key":"2026032708450718000_13.1.e003793.12","unstructured":"NICE: Lung Cancer . Diagnosis and management. 2024. Available: https:\/\/www.nice.org.uk\/guidance\/ng122"},{"key":"2026032708450718000_13.1.e003793.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112431"},{"key":"2026032708450718000_13.1.e003793.14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2021.08.008","article-title":"Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer","volume":"161","author":"Moore","year":"2021","journal-title":"Lung Cancer (Auckl)"},{"key":"2026032708450718000_13.1.e003793.15","unstructured":"Sarah cannon molecular diagnostics: legacy NGS panel details. 2026 Available: https:\/\/sarahcannon-md.co.uk\/home\/our-tests\/ngs-assay-details\/legacy-ngs-panels\/"},{"key":"2026032708450718000_13.1.e003793.16","unstructured":"NHS Health Research Authority . Do i need NHS rec review? 2022 Available: http:\/\/www.hra-decisiontools.org.uk\/ethics\/"},{"key":"2026032708450718000_13.1.e003793.17","unstructured":"Systemic anti-cancer therapy for advanced nonsmallcell lung cancer: treatment options. 2025 Available: https:\/\/www.nice.org.uk\/guidance\/ng122\/resources\/interactive-pdf-of-all-treatment-pathways-for-squamous-and-nonsquamous-advanced-nonsmallcell-lung-cancer-pdf-11189888174"},{"key":"2026032708450718000_13.1.e003793.18","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219698"},{"key":"2026032708450718000_13.1.e003793.19","doi-asserted-by":"crossref","unstructured":"Adizie JB , Tweedie J , Khakwani A , et al . Biomarker Testing for People With Advanced Lung Cancer in England. JTO Clin Res Rep 2021;2. doi:10.1016\/j.jtocrr.2021.100176","DOI":"10.1016\/j.jtocrr.2021.100176"},{"key":"2026032708450718000_13.1.e003793.20","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217959"},{"key":"2026032708450718000_13.1.e003793.21","doi-asserted-by":"crossref","unstructured":"Zhang Y , Shi L , Simoff MJ , et al . Biopsy frequency and complications among lung cancer patients in the United States. Lung Cancer Manag 2020;9. doi:10.2217\/lmt-2020-0022","DOI":"10.2217\/lmt-2020-0022"},{"key":"2026032708450718000_13.1.e003793.22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.21037\/tlcr-19-675","article-title":"Impact of time-to-treatment on overall survival of non-small cell lung cancer patients-an analysis of the national cancer database","volume":"9","author":"Anggondowati","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"2026032708450718000_13.1.e003793.23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lungcan.2022.01.018","article-title":"A systematic review and meta-analysis of the adequacy of endobronchial ultrasound transbronchial needle aspiration for next-generation sequencing in patients with non-small cell lung cancer","volume":"166","author":"Zhao","year":"2022","journal-title":"Lung Cancer (Auckl)"},{"key":"2026032708450718000_13.1.e003793.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.02.011"},{"key":"2026032708450718000_13.1.e003793.25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0099"},{"key":"2026032708450718000_13.1.e003793.26","doi-asserted-by":"crossref","unstructured":"Bange E , Marmarelis ME , Hwang WT , et al . Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol 2019.","DOI":"10.1200\/PO.18.00326"},{"key":"2026032708450718000_13.1.e003793.27","doi-asserted-by":"crossref","unstructured":"von Ahlfen S , Missel A , Bendrat K , et al . Determinants of RNA quality from FFPE samples. PLoS One 2007;2. doi:10.1371\/journal.pone.0001261","DOI":"10.1371\/journal.pone.0001261"},{"key":"2026032708450718000_13.1.e003793.28","doi-asserted-by":"crossref","unstructured":"Desmeules P , Boudreau DK , Bastien N , et al . Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC. JTO Clin Res Rep 2022;3. doi:10.1016\/j.jtocrr.2022.100276","DOI":"10.1016\/j.jtocrr.2022.100276"},{"key":"2026032708450718000_13.1.e003793.29","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318267223a"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:45:22Z","timestamp":1774626322000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjresp-2025-003793"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003793","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}